Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mikko Neuvonen

Showing results (31-40 of 104) with videos related to

Pageof 11
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 16, 2002
Gemfibrozil inhibits CYP2C8-mediated cerivastatin metabolism in human liver microsomesJun-Sheng Wang, Mikko Neuvonen, Xia Wen, et al.
European Journal of Clinical Pharmacology|November 8, 2007
Effect of voriconazole and fluconazole on the pharmacokinetics of intravenous fentanylTeijo I Saari, Kari Laine, Mikko Neuvonen, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|December 1, 2009
High performance liquid chromatography-tandem mass spectrometry for the determination of bile acid concentrations in human plasmaXiaoqiang Xiang, Yi Han, Mikko Neuvonen, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 3, 2012
Autoinhibition of CYP3A4 leads to important role of CYP2C8 in imatinib metabolism: variability in CYP2C8 activity may alter plasma concentrations and responseAnne M Filppula, Mikko Neuvonen, Jouko Laitila, et al.
Pharmacogenetics and Genomics|May 29, 2015
SLCO1B1 polymorphism markedly affects the pharmacokinetics of lovastatin acidAleksi Tornio, Juha Vakkilainen, Mikko Neuvonen, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 12, 2019
Clopidogrel and Gemfibrozil Strongly Inhibit the CYP2C8-Dependent Formation of 3-Hydroxydesloratadine and Increase Desloratadine Exposure In HumansMatti K Itkonen, Aleksi Tornio, Mikko Neuvonen, et al.
Clinical Pharmacology and Therapeutics|October 4, 2005
Cyclosporine markedly raises the plasma concentrations of repaglinideLauri I Kajosaari, Mikko Niemi, Mikko Neuvonen, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|March 2, 2026
In vitro inhibition of organic anion transporting polypeptide 2B1 (OATP2B1) is common among marketed drugsMohsin Ali Raza, Alli Sinokki, Marju Monnonen, et al.
Clinical and Translational Science|March 22, 2024
Non-targeted metabolomics for the identification of plasma metabolites associated with organic anion transporting polypeptide 1B1 functionKreetta Hämäläinen, Päivi Hirvensalo, Mikko Neuvonen, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 5, 2016
Clopidogrel Markedly Increases Plasma Concentrations of CYP2C8 Substrate PioglitazoneMatti K Itkonen, Aleksi Tornio, Mikko Neuvonen, et al.
Pageof 11

Showing results (31-40 of 104) with videos related to

Sort By:
Pageof 11
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 16, 2002
Gemfibrozil inhibits CYP2C8-mediated cerivastatin metabolism in human liver microsomesJun-Sheng Wang, Mikko Neuvonen, Xia Wen, et al.
European Journal of Clinical Pharmacology|November 8, 2007
Effect of voriconazole and fluconazole on the pharmacokinetics of intravenous fentanylTeijo I Saari, Kari Laine, Mikko Neuvonen, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|December 1, 2009
High performance liquid chromatography-tandem mass spectrometry for the determination of bile acid concentrations in human plasmaXiaoqiang Xiang, Yi Han, Mikko Neuvonen, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 3, 2012
Autoinhibition of CYP3A4 leads to important role of CYP2C8 in imatinib metabolism: variability in CYP2C8 activity may alter plasma concentrations and responseAnne M Filppula, Mikko Neuvonen, Jouko Laitila, et al.
Pharmacogenetics and Genomics|May 29, 2015
SLCO1B1 polymorphism markedly affects the pharmacokinetics of lovastatin acidAleksi Tornio, Juha Vakkilainen, Mikko Neuvonen, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 12, 2019
Clopidogrel and Gemfibrozil Strongly Inhibit the CYP2C8-Dependent Formation of 3-Hydroxydesloratadine and Increase Desloratadine Exposure In HumansMatti K Itkonen, Aleksi Tornio, Mikko Neuvonen, et al.
Clinical Pharmacology and Therapeutics|October 4, 2005
Cyclosporine markedly raises the plasma concentrations of repaglinideLauri I Kajosaari, Mikko Niemi, Mikko Neuvonen, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|March 2, 2026
In vitro inhibition of organic anion transporting polypeptide 2B1 (OATP2B1) is common among marketed drugsMohsin Ali Raza, Alli Sinokki, Marju Monnonen, et al.
Clinical and Translational Science|March 22, 2024
Non-targeted metabolomics for the identification of plasma metabolites associated with organic anion transporting polypeptide 1B1 functionKreetta Hämäläinen, Päivi Hirvensalo, Mikko Neuvonen, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 5, 2016
Clopidogrel Markedly Increases Plasma Concentrations of CYP2C8 Substrate PioglitazoneMatti K Itkonen, Aleksi Tornio, Mikko Neuvonen, et al.
Pageof 11